Ryotaro Teranaka   Hiroshi Fujimoto   Takahito Masuda   Masayuki Kuroda   Yasuyuki Aoyagi   Takeshi Nagashima   Mamoru Takada   Junta Sakakibara   Hideyuki Yamada   Hiroto Yamamoto   Yoshitaka Kubota   Masayuki Ohtsuka   
Breast cancer (Tokyo, Japan) 2023年8月
BACKGROUND: Although targeted treatments against human epidermal growth factor receptor 2 (HER2) have improved survival in patients with metastatic HER2-positive breast cancer, long and repeated treatment is time-consuming and costly for patients....